Cambridge Investment Research Advisors, Inc.
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1419186
FAIRFIELD, IA
Position in REGN
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$3,733,396
-$41,048 QoQ
Shares Held
4,832
-1.2% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Cambridge Investment Research Advisors, Inc. holds $49,299,867 across 75 Biotechnology names. REGN ranks #4 (7.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
15,955 | $7,124,545 | |
| 2 | EXEL |
Exelixis, Inc.
|
159,749 | $6,851,634 | |
| 3 | NKTR |
Nektar Therapeutics
|
56,055 | $4,033,157 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
4,832 | $3,733,396 | |
| 5 | IBRX |
ImmunityBio, Inc.
|
284,704 | $2,183,679 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
29,059 | $2,157,921 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
37,992 | $1,807,279 | |
| 8 | CORT |
Corcept Therapeutics Inc
|
42,754 | $1,723,413 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,733,396 | 4,832 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $3,774,444 | 4,890 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $2,260,887 | 4,021 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,050,125 | 3,905 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $2,486,181 | 3,920 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $3,084,388 | 4,330 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $5,617,826 | 5,344 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $5,445,386 | 5,181 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $5,043,447 | 5,240 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $7,134,349 | 8,123 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $8,333,292 | 10,126 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $3,085,410 | 4,294 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $4,750,074 | 5,781 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $4,626,915 | 6,413 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $4,906,821 | 7,123 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $5,705,586 | 9,652 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $6,938,802 | 9,935 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $6,685,270 | 10,586 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $6,095,978 | 10,073 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $6,645,508 | 11,898 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $5,432,120 | 11,481 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $6,631,650 | 13,727 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $6,103,841 | 10,904 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $9,283,030 | 14,885 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $4,034,740 | 8,263 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||